Literature DB >> 74365

Fc-rosette inhibition by pregnant women's sera and by rabbit anti-beta2-microglobulin.

T Morito, K Tanimoto, Y Horiuchi, T Juji.   

Abstract

Some anti-HLA sera showed Fc-rosette inhibitory activity, which had little correlation with type-specific anti-HLA activity. Cytotoxic titers did not correlate with Fc-rosette inhibition rate and these antisera showed considerable inhibition of rosette formation even after absorption of anti-HLA activity with T lymphocytes. These results suggest that some anti-HLA sera contain B-cell-specific inhibitory activity against Fc-receptor like anti-Ia antibody in mice. Rabbit antiserum against human beta2-microglobulin showed specific inhibition of Fc-rosette formation. It was suggested that Fc-receptor or Ia-like antigen in human has a close relation with beta2-microglobulin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 74365     DOI: 10.1159/000232028

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  5 in total

1.  Detection of antilymphocyte antibody with two-color method in systemic lupus erythematosus and its heterogeneous specificities against human T-cell subsets.

Authors:  K Okudaira; H Nakai; T Hayakawa; T Kashiwado; K Tanimoto; Y Horiuchi; T Juji
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

2.  Modulation of Fc receptors on human peripheral blood lymphocytes by antisera against beta 2 microglobulin, Ia or immunoglobulin.

Authors:  G Sarmay; A Sanderson; J Ivanyi
Journal:  Immunology       Date:  1979-02       Impact factor: 7.397

Review 3.  Intravenous immune globulin in recurrent abortion.

Authors:  O Heine; G Mueller-Eckhardt
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

4.  T lymphocyte interaction with immunoglobulin G antibody in systemic lupus erythematosus.

Authors:  K Okudaira; R P Searles; K Tanimoto; Y Horiuchi; R C Williams
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

5.  Pathopysiological aspects of immune complex diseases. Part II. Phagocytosis, exocytosis, and pathogenic depositions.

Authors:  H H Sedlacek
Journal:  Klin Wochenschr       Date:  1980-06-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.